Neurofibromatosis 1 has a germ line mutation in the NF1 tumor suppression gene.2 There are various subtypes of neurofibromas including focal cutaneous, diffuse cutaneous, subcutaneous, deep nodular, and diffuse plexiform. Plexiform neurofibromas develop in about half of the individuals with neurofibromatosis 1, 3,4 and are the major cause of morbidity and disfigurement. This particular variant can also progress to malignant peripheral nerve sheath tumor (MPNST), one of the leading causes of death among patients with neurofibromatosis 1.
3Case Report A 2-day old male neonate with a 35-5/7 week gestation and birth weight of 2664 grams was referred to our institution for evaluation and management of a mass on left side of his neck. Labor and delivery was complicated by pregnancyinduced hypertension, premature rupture of membranes, and nonreassuring fetal heart rate. Delivery was via an emergent cesarean section. The Apgar scores were 2, 6, and 8 at 1, 5, and 10 minutes, respectively. There was no known family history suggestive of neurofibromatosis 1. Prenatal ultrasound performed at 32 weeks of gestation was normal. We describe a premature neonate with an extensive plexiform neurofibroma. Prenatal ultrasound at 32 weeks of gestation was normal. Postnatal examination was significant for a palpable left neck mass. Magnetic resonance imaging (MRI) of the head demonstrated a mass involving the left cavernous sinus with spreading to the left orbital region. MRI of the neck was positive for extensive adenopathy, left more than right, with extension into the deep face region and infratemporal fossa on the left side. MRI of the chest, abdomen, and pelvis demonstrated a mass extending from the superior mediastinum to the left pelvic retroperitoneal region, including the mesenteric vasculature and spinal canal at multiple levels with compression of the spinal cord. Biopsy of the left neck mass confirmed for plexiform neurofibroma. A careful search of the literature revealed no previous report of such an extensive neurofibroma in a premature neonate. Surgical decompression in this premature neonate was not possible because of the extensive nature of the disease; it is known that neurofibroma is non-respondent to chemotherapy and radiotherapy. Therefore, alternative treatment is needed to improve the outcome.